As part of international cooperation with Chinese universities, 23 students from Al-Farabi Kazakh National University successfully completed an internship at the prestigious Shenzhen University Summer School

23 july, 2024

From July 13 to July 21, 2024, a delegation from Al-Farabi Kazakh National University (KazNU), consisting of 23 students from the Faculty of Biology and Biotechnology and the School of Medicine, participated in the International Summer School on Molecular Medicine and Bioengineering.

Shenzhen University (SZU), established in 1983, has become one of the leading innovators in higher education. SZU ranks among the top 400 world-renowned universities and is among the top 30 Chinese universities. The university offers a wide range of undergraduate and graduate programs, providing students with an interdisciplinary and inclusive multicultural learning environment aimed at encouraging academic excellence and discovering new interests and opportunities in a rapidly changing era.

The SZU Medical School, founded in December 2008, is the first medical school in Shenzhen. The school employs 627 faculty members, most of whom have studied or worked abroad, with 96.3% holding doctoral degrees. The school's nationally recognized scientific achievements in medicine include genomic medicine, immunology, cancer research, aging and metabolism, drug discovery, artificial intelligence imaging, medical equipment development, orthopedics, neurosurgery, burn surgery, and pain management.

As part of international cooperation with Chinese universities, 23 students from Al-Farabi Kazakh National University successfully completed an internship at the prestigious Shenzhen University Summer School.

The selected students had the opportunity to immerse themselves in an intensive educational environment and familiarize themselves with advanced scientific research in biomedical engineering. The program included lecture courses by outstanding professors from Shenzhen University, who specialize in key areas of medical sciences.

One of the main topics covered during the internship was "Genetic Instability and Diseases." Professors Xingzhi Xu, Sunichi Takeda, Wei-Gu Zhu, and Yuan Su shared their knowledge and experience in this field of molecular biology and genetic engineering. Another important aspect of the internship was aging and metabolic diseases. Professors Baohua Liu and Jie Liu unveiled current trends and achievements in this field of medicine to the students.

 

Professor Xinchun Chen and Associate Professor Xue Liu explained to the students the mechanisms of interaction between the immune system and infections and the importance of an effective immune response. A vital part of the internship was the introduction to nanomedicine. In addition to lectures, students had the opportunity to visit laboratories at Shenzhen University's Medical School and gain practical experience working with cutting-edge technologies.

Having completed the internship at the summer school, the students from Al-Farabi Kazakh National University gained valuable experience and knowledge. This internship not only provided an opportunity for in-depth learning but also served as a means of broadening horizons and strengthening international ties in biomedical engineering between Kazakhstan and China.

During the summer school, the Dean of the Faculty, Meruert Sakenovna Kurmanbayeva, Head of the Department of Policy and Organization in Medicine, Gulnara Kapanova, and Head of the Department of Biotechnology, Aida Kistaubayeva, successfully exchanged experiences and knowledge.

While at Shenzhen University, KazNU faculty members not only familiarized themselves with cutting-edge research and innovations in medicine and biotechnology but also established strong professional connections with researchers and professors from this university. The continuation of scientific collaboration between KazNU and Shenzhen University promises to bring new prospects and achievements. This is an important step in developing the scientific potential of both universities and contributing to the future of medical and biotechnological sciences.